Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$165.66
-2.69-1.59%
Last update: Oct 12, 2:53 PM
Axsome Therapeutics Inc (AXSM) Stock Price, Quote, News & History
AXSMNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Axsome Therapeutics (NASDAQ:AXSM) through any online brokerage.
Other companies in Axsome Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Axsome Therapeutics has a consensus price target of $238.92.
The stock price for Axsome Therapeutics (NASDAQ: AXSM) is $165.665 last updated October 12, 2026 at 2:53 PM EDT.
There are no upcoming dividends for Axsome Therapeutics.
Axsome Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Axsome Therapeutics.
Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
